TGFB1 and ovarian cancer: While mutations in Smad gene sequences are uncommon [46,47], the reduced expression and decreased binding ability of the Smad4 protein, which is required for the nuclear translocation of TGF-β signaling through the canonical pathway, is found at a higher frequency in ovarian cancers compared to normal ovarian tissue [48,49].